JPS6051190A - トリアゾロ−ピリミジン誘導体、その製法ならびにそれを含有する強心剤 - Google Patents

トリアゾロ−ピリミジン誘導体、その製法ならびにそれを含有する強心剤

Info

Publication number
JPS6051190A
JPS6051190A JP59155127A JP15512784A JPS6051190A JP S6051190 A JPS6051190 A JP S6051190A JP 59155127 A JP59155127 A JP 59155127A JP 15512784 A JP15512784 A JP 15512784A JP S6051190 A JPS6051190 A JP S6051190A
Authority
JP
Japan
Prior art keywords
pyridyl
group
branched
pyrimidine
triazolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP59155127A
Other languages
English (en)
Japanese (ja)
Inventor
ジエラルド バルテルミー
ジヤン―ノエル ヴアラ
アンドレ アロ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of JPS6051190A publication Critical patent/JPS6051190A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Manufacturing Of Printed Wiring (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
JP59155127A 1983-07-25 1984-07-25 トリアゾロ−ピリミジン誘導体、その製法ならびにそれを含有する強心剤 Pending JPS6051190A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8312443 1983-07-25
FR8312443A FR2549834B1 (fr) 1983-07-25 1983-07-25 Derives de triazolo-pyrimidine, leur procede de preparation et leur application therapeutique en tant que tonicardiaques

Publications (1)

Publication Number Publication Date
JPS6051190A true JPS6051190A (ja) 1985-03-22

Family

ID=9291173

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59155127A Pending JPS6051190A (ja) 1983-07-25 1984-07-25 トリアゾロ−ピリミジン誘導体、その製法ならびにそれを含有する強心剤

Country Status (27)

Country Link
US (1) US4581358A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0136198B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS6051190A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR870001200B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE32462T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU562596B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1226284A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS248718B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD222593A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3469300D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK360584A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES534550A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI842966A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2549834B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR82222B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU190653B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL72330A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MA (1) MA20186A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO843003L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ208991A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
OA (1) OA07755A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH20003A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL248923A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT78970B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU1347865A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU131784A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA845301B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020504743A (ja) * 2016-12-22 2020-02-13 カデント セラピューティクス,インコーポレーテッド Nmda受容体モジュレーターおよびその使用
US11542264B2 (en) 2018-08-03 2023-01-03 Cadent Therapeutics, Inc. Heteroaromatic NMDA receptor modulators and uses thereof
US12162890B2 (en) 2015-12-09 2024-12-10 Novartis Ag Heteroaromatic NMDA receptor modulators and uses thereof

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666908A (en) * 1985-04-05 1987-05-19 Warner-Lambert Company 5-Substituted pyrazolo[4,3-d]pyrimidine-7-ones and methods of use
US4883872A (en) * 1987-11-25 1989-11-28 E. R. Squibb & Sons, Inc. 3-oxo-1,2,4-triazolo(4,3-A) pyrimidine-6-carboxylic acid esters
US4892945A (en) * 1987-12-21 1990-01-09 Ciba-Geigy Corporation Isoindoline pigments containing at least one triazolopyrimidone radical
IL108747A (en) * 1993-03-04 1999-03-12 Shell Int Research Mushroom-killing preparations containing a history of 6 metamorphoses of 5 - 7 Dihalo - 1, 2 - 4 Triazlo [A-1,5] Pyrimidine Certain such new compounds and their preparation
GB9321162D0 (en) * 1993-10-13 1993-12-01 Boots Co Plc Therapeutic agents
US5488109A (en) * 1993-11-05 1996-01-30 Dowelanco 5-alkoxy[1,2,4]triazolo[1,5-c]pyrimidine-2(3H)--thione compounds and their use in the preparation of and 2-chlorosulfonyl-5-alkoxy[1,2,4]triazolo[1,5-c]-pyrimidine compounds
KR100324966B1 (ko) * 1999-04-13 2002-02-25 서정윤 알루미늄제품의 전해착색법
JP2001302667A (ja) * 2000-04-28 2001-10-31 Bayer Ag イミダゾピリミジン誘導体およびトリアゾロピリミジン誘導体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB845552A (en) * 1955-10-26 1960-08-24 Farmaceutici Italia Pyrimidine derivatives
US4209621A (en) * 1979-04-27 1980-06-24 American Cyanamid Company (Substituted-phenyl)-1,2,4-triazolo[4,3-a]-pyrimidines and (substituted-phenyl)-1,2,4-triazolo[1,5-a]pyrimidines

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12162890B2 (en) 2015-12-09 2024-12-10 Novartis Ag Heteroaromatic NMDA receptor modulators and uses thereof
JP2020504743A (ja) * 2016-12-22 2020-02-13 カデント セラピューティクス,インコーポレーテッド Nmda受容体モジュレーターおよびその使用
US11274107B2 (en) 2016-12-22 2022-03-15 Cadent Therapeutics, Inc. NMDA receptor modulators and uses thereof
US11807650B2 (en) 2016-12-22 2023-11-07 Novartis Ag NMDA receptor modulators and uses thereof
US12358929B2 (en) 2016-12-22 2025-07-15 Novartis Ag NMDA receptor modulators and uses thereof
US11542264B2 (en) 2018-08-03 2023-01-03 Cadent Therapeutics, Inc. Heteroaromatic NMDA receptor modulators and uses thereof

Also Published As

Publication number Publication date
DE3469300D1 (en) 1988-03-17
FI842966A0 (fi) 1984-07-25
DK360584D0 (da) 1984-07-23
HUT34753A (en) 1985-04-28
AU3079184A (en) 1985-01-31
ATE32462T1 (de) 1988-02-15
FR2549834A1 (fr) 1985-02-01
CS248718B2 (en) 1987-02-12
GR82222B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-12-13
IL72330A0 (en) 1984-11-30
MA20186A1 (fr) 1985-04-01
PT78970B (fr) 1986-06-05
EP0136198B1 (fr) 1988-02-10
EP0136198A1 (fr) 1985-04-03
CA1226284A (fr) 1987-09-01
ES8504806A1 (es) 1985-05-01
PL248923A1 (en) 1985-05-07
AU562596B2 (en) 1987-06-11
KR870001200B1 (ko) 1987-06-20
NZ208991A (en) 1987-07-31
US4581358A (en) 1986-04-08
YU131784A (en) 1986-06-30
PT78970A (fr) 1984-08-01
OA07755A (fr) 1985-08-30
FI842966A7 (fi) 1985-01-26
FR2549834B1 (fr) 1985-10-18
DD222593A5 (de) 1985-05-22
NO843003L (no) 1985-01-28
PH20003A (en) 1986-08-28
SU1347865A3 (ru) 1987-10-23
HU190653B (en) 1986-10-28
ZA845301B (en) 1985-02-27
DK360584A (da) 1985-01-26
ES534550A0 (es) 1985-05-01
IL72330A (en) 1987-02-27
KR850001214A (ko) 1985-03-16

Similar Documents

Publication Publication Date Title
JPS6056143B2 (ja) アミジン誘導体ならびにその製造法
CN107556317B (zh) 一种咪唑吡嗪胺苯基衍生物及其用途
CN101094853A (zh) 可用作蛋白激酶抑制剂的吡唑并[1,5-a]嘧啶
CZ9797A3 (en) Triazole derivative, process of its preparation and pharmaceutical composition containing thereof
CN116568681A (zh) Sos1抑制剂、包含其的药物组合物及其用途
KR20230058466A (ko) 신규한 rho-연관 단백질 인산화효소 억제제의 제조 방법 및 제조 방법 중의 중간체
JP7611934B2 (ja) ピラゾロピリダジノン化合物、その医薬組成物及びその用途
JP5583698B2 (ja) プロテインキナーゼablおよびsrcの阻害剤としてのアザインドール誘導体
JPS6051190A (ja) トリアゾロ−ピリミジン誘導体、その製法ならびにそれを含有する強心剤
JPH0499768A (ja) 4―(4―フェニルピリジン―2―イル)ピペラジン―1―オキシド誘導体
US4305944A (en) N-[(4-[3-cyano substituted pyridyl]piperazino)alkyl]-azaspirodecanediones
NO802507L (no) 6-pyridazinoner med kardiotonisk virkning.
ZA200105475B (en) Utilization of pyrimidine derivatives for preventing and treating cerebral ischhaemia.
CA1084929A (en) 1,2,4-triazolo 4,3-b pyridazin-3-ones
JPS58110585A (ja) イミダゾ(4,5−c)ピリジン化合物これらの化合物を含有する医薬製剤およびそれらの製造方法
RU2200737C2 (ru) Пиримидо[4,5-b]индолы и промежуточное соединение (варианты)
HU191126B (en) Process for producing new n-imino-pyridinium-betaine derivatives and pharmaceutical compositions containing them as active agents
AU2023226510A1 (en) Use of hpk1 inhibitor in treatment of interferon-related diseases
US4353903A (en) 2,3-Dihydro-imidazo[1,2-b]pyridazine derivatives, their preparation and use in treatment of depression
CA1051895A (en) Derivatives of 1h-triazolo(4,5-c)pyridine-7-carboxylic acids and esters
WO1999051606A1 (fr) Derives de triazolopurine, composition medicinale contenant lesdits derives, agent de compatibilisation de recepteur de l'adenosine a3, et medicament contre l'asthme
US4085102A (en) 2-Amino-8-arylideno-3,4,5,6,7,8-hexahydro-4-arlypyrido[4,3-d]pyrimidines
JPH0662608B2 (ja) カルボスチリル誘導体
US4337253A (en) 4,5-Dihydro-2-methyl-6-(4-pyridinyl)-3(2H)-pyridazinone and its use as a cardiotonic
JPS5857380A (ja) 9,10−置換2−メシチルイミノ−3−アルキル−3,4,6,7−テトラヒドロ−2H−ピリミド(6.1−a)イソキノリン−4−オン